Trending...
- Australian Aboriginal Cultural Immersions and First Nations Workshops
- Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
PITTSBURGH, April 8, 2024 ~ EQT Corporation (NYSE: EQT) has announced its plans to release its first quarter financial and operating results after the market closes on Tuesday, April 23, 2024. The company will also be hosting a conference call on Wednesday, April 24, 2024 at 10:00 a.m. ET to discuss the results and other relevant matters. A brief Q&A session for securities analysts will follow the discussion.
More on The PennZone
Investors can access the live audio webcast of the conference call by visiting EQT's investor relations website at ir.eqt.com. A replay of the call will also be available for one year in the same location after the conclusion of the live event.
Cameron Horwitz, Managing Director of Investor Relations & Strategy, can be contacted for any further inquiries at 412.395.2555.
More on The PennZone
- 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
- Tickeron Launches Next-Gen AI Corridor Bots: Consistent Exits for Stocks and ETFs
- From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
- Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
- Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
Investors can access the live audio webcast of the conference call by visiting EQT's investor relations website at ir.eqt.com. A replay of the call will also be available for one year in the same location after the conclusion of the live event.
Cameron Horwitz, Managing Director of Investor Relations & Strategy, can be contacted for any further inquiries at 412.395.2555.
Filed Under: Business
0 Comments
Latest on The PennZone
- New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
- BRAG Hosts Holiday Benefit — Awards 10 Student Scholarships & Honors Timberland with the Corporate Impact Award
- FittingPros Launches Industry's First Data-Driven Golf Club Fitting Directory
- African American Genealogy Group Launches 2025 Raffle Fundraiser to Support Legacy Research
- Take Control of Your Color Matching with Boston Industrial Solutions' Newly Expanded Natron® UVPX Series Ink Colors
- "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
- Kaufman Development Breaks Ground on Detroit Micro Data Center, Expanding Its National AI Platform
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
- Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
- LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
- Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
- Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
- Ring in the Season with Free Holiday Jazz from The Jazz Sanctuary
- America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough